8.15 (-%)
As of Nov 01, 2024
Source:
Gh Research Plc is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Our initial focus is on developing our novel and proprietary mebufotenin therapies for the treatment of patients with treatment-resistant depression, or TRD.
| Country | Ireland |
| Headquarters | dublin 2, ireland |
| Phone Number | 353 1 437 8334 |
| Industry | manufacturing |
| CEO | Theis Terwey |
| Website | www.ghres.com |